Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. (Q40890664)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. |
scientific article |
Statements
1 reference
Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154. (English)
1 reference
Mackey MF
1 reference
Gunn JR
1 reference
Ting PP
1 reference
Kikutani H
1 reference
Dranoff G
1 reference
Noelle RJ
1 reference
Barth RJ Jr
1 reference
1 July 1997
1 reference
1 reference